Valeric acid acts as a novel HDAC3 inhibitor against prostate cancer
Rui Han(Guangzhou University of Chinese Medicine), Lingeng Lu(Yale Cancer Center)
Cited by 30
Related Papers
RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
|Scientific Reports|2021|42
Antioxidant protein peroxiredoxin 6 suppresses the vascular inflammation, oxidative stress and endothelial dysfunction in angiotensin II-induced endotheliocyte
|General Physiology and Biophysics|2020|13